Related Experiment Videos
Structure-based design of transcription factors
J L Pomerantz1, P A Sharp, C O Pabo
1Department of Biology, Massachusetts Institute of Technology, Cambridge 02139.
Summary
Researchers designed novel transcription factors by combining DNA binding domains. A fusion protein, ZFHD1, demonstrated sequence-specific DNA binding and gene regulation, showing potential for designing new proteins.
Area of Science:
- Molecular Biology
- Protein Engineering
- Bioinformatics
Background:
- Transcription factors regulate gene expression by binding to specific DNA sequences.
- Designing novel transcription factors with specific DNA-binding capabilities is a key goal in synthetic biology.
- Existing DNA binding domains offer a foundation for creating engineered proteins.
Purpose of the Study:
- To test a structure-based strategy for designing transcription factors with novel sequence specificities.
- To construct and characterize a fusion protein combining known DNA binding domains.
- To evaluate the in vivo gene regulatory function of the engineered transcription factor.
Main Methods:
- Computer modeling to predict novel DNA binding specificities.
- Construction of a fusion protein (ZFHD1) integrating zinc finger and homeodomain DNA binding motifs.
- DNA binding assays to determine optimal binding sequences.
- In vivo reporter assays to assess promoter regulation by the engineered protein.
Main Results:
- The fusion protein ZFHD1 exhibited specific binding to a DNA sequence containing adjacent homeodomain and zinc finger subsites.
- ZFHD1, when fused to an activation domain, demonstrated sequence-specific regulation of promoter activity in vivo.
- The study validates a modular approach for designing synthetic transcription factors.
Conclusions:
- A structure-based strategy enables the rational design of transcription factors with novel DNA sequence specificities.
- Engineered fusion proteins can achieve specific DNA binding and functional gene regulation.
- This approach holds promise for the broader design of custom DNA-binding proteins for various applications.